We also examined the frequency and clinical significance of the TSHZ2 expression in a retrospective series of 226 patients who underwent lung adenocarcinoma resection and analyzed its impact on the patients' prognosis. The gene discussed is TSHZ2; the disease is lung adenocarcinoma.